Thamer A. Alsubi

In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2020, RSC Advances.

Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2019, Royal Society Open Science.

Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case study

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.